Skip to main content
. 2017 Jul 18;8:480. doi: 10.3389/fphar.2017.00480

FIGURE 3.

FIGURE 3

Relaxing responses to the PAR-2 agonist SLIGRL in isolated MRA; effects of apixaban (APX). The vasodilatation to SLIGRL was assessed in intact arteries, in the absence (A) or in the presence (B) of NG-nitro-L-arginine (L-NNA, 0.1 mM), to block endogenous NO, or in endothelium-denuded arteries (C). MRA was pre-constricted with 1 μM phenylephrine. Data are the mean ± SEM of 8–12 independent measurements. P < 0.01 versus Control. Two-way ANOVA.